{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:29:55Z","timestamp":1790720995867,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD088626"],"award-info":[{"award-number":["HD088626"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD087795"],"award-info":[{"award-number":["HD087795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002889","name":"Foundation for Prader-Willi Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HD088626"],"award-info":[{"award-number":["HD088626"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HD087795"],"award-info":[{"award-number":["HD087795"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.trsl.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T02:26:57Z","timestamp":1551752817000},"page":"105-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Epigenetic therapy of Prader\u2013Willi syndrome"],"prefix":"10.1016","volume":"208","author":[{"given":"Yuna","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.02.012_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader-Willi syndrome","volume":"17","author":"Cassidy","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1542\/peds.113.3.565","article-title":"Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy","volume":"113","author":"Butler","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.trsl.2019.02.012_bib0003","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ncpendmet0320","article-title":"Management of obesity in Prader-Willi syndrome","volume":"2","author":"Butler","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0004","first-page":"278","article-title":"Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases","volume":"34","author":"Ledbetter","year":"1982","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM198102053040604","article-title":"Deletions of chromosome 15 as a cause of the Prader-Willi syndrome","volume":"304","author":"Ledbetter","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0006","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ajmg.1320280407","article-title":"Is Angelman syndrome an alternate result of del(15)(q11q13)?","volume":"28","author":"Magenis","year":"1987","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ejhg.2014.66","article-title":"Clinical utility gene card for: Prader-Willi syndrome","volume":"22","author":"Buiting","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0008","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0959-437X(98)80091-9","article-title":"Imprinting in Angelman and Prader-Willi syndromes","volume":"8","author":"Jiang","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.trsl.2019.02.012_bib0009","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0140-6736(91)90278-W","article-title":"Uniparental paternal disomy in Angelman's syndrome","volume":"337","author":"Malcolm","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome","volume":"342","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0011","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/ajmg.a.32364","article-title":"Mechanisms of imprinting of the Prader-Willi\/Angelman region","volume":"146A","author":"Horsthemke","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0012","series-title":"GeneReviews((R))","article-title":"Prader-Willi syndrome","author":"Driscoll","year":"1993"},{"key":"10.1016\/j.trsl.2019.02.012_bib0013","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0009922815617973","article-title":"Growth charts for Prader-Willi syndrome during growth hormone treatment","volume":"55","author":"Butler","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.trsl.2019.02.012_bib0014","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader-Willi syndrome","volume":"155A","author":"Miller","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajmg.a.38582","article-title":"Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: a review of natural history study","volume":"176","author":"Butler","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0016","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/jmedgenet-2017-105118","article-title":"Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome","volume":"55","author":"Singh","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpeds.2006.04.013","article-title":"Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity","volume":"149","author":"Miller","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2019.02.012_bib0019","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajmg.a.30771","article-title":"Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome","volume":"136","author":"Hartley","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(02)07340-3","article-title":"Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy","volume":"359","author":"Boer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-9525(98)01555-8","article-title":"Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits","volume":"14","author":"Lupski","year":"1998","journal-title":"Trends Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0022","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/302233","article-title":"Imprinting-mutation mechanisms in Prader-Willi syndrome","volume":"64","author":"Ohta","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0023","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ng0994-52","article-title":"Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region","volume":"8","author":"Sutcliffe","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng0495-395","article-title":"Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15","volume":"9","author":"Buiting","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0026","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ajmg.a.31520","article-title":"Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study","volume":"143A","author":"Torrado","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0027","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-7610.2005.01520.x","article-title":"Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype","volume":"46","author":"Milner","year":"2005","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.trsl.2019.02.012_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-0004.2005.00377.x","article-title":"Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients","volume":"67","author":"Varela","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1352\/0895-8017(1999)104<0067:MBDIPS>2.0.CO;2","article-title":"Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy","volume":"104","author":"Dykens","year":"1999","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.trsl.2019.02.012_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0033291702006736","article-title":"Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome","volume":"33","author":"Holland","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0031","doi-asserted-by":"crossref","first-page":"e72640","DOI":"10.1371\/journal.pone.0072640","article-title":"Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects\u2013a meta analysis","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.012_bib0032","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041444-200512000-00006","article-title":"Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review","volume":"15","author":"Veltman","year":"2005","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00787-004-0354-6","article-title":"Prader-Willi syndrome\u2013a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders","volume":"13","author":"Veltman","year":"2004","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.trsl.2019.02.012_bib0034","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2788.2006.00895.x","article-title":"The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment","volume":"51","author":"Soni","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.trsl.2019.02.012_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.c.30273","article-title":"Prader-Willi syndrome and Angelman syndrome","volume":"154C","author":"Buiting","year":"2010","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0036","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000090844","article-title":"Imprinting defects on human chromosome 15","volume":"113","author":"Horsthemke","year":"2006","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.trsl.2019.02.012_bib0037","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1387\/ijdb.140077mb","article-title":"Epigenetics and imprinting in human disease","volume":"58","author":"Kalish","year":"2014","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a018382","article-title":"Genomic imprinting in mammals","volume":"6","author":"Barlow","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a002592","article-title":"Mammalian genomic imprinting","volume":"3","author":"Bartolomei","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature23262","article-title":"Maternal H3K27me3 controls DNA methylation-independent imprinting","volume":"547","author":"Inoue","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0041","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1086\/302917","article-title":"Parent-of-origin specific histone acetylation and reactivation of a key imprinted gene locus in Prader-Willi syndrome","volume":"66","author":"Saitoh","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0042","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/366362a0","article-title":"Role for DNA methylation in genomic imprinting","volume":"366","author":"Li","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0043","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019133","article-title":"DNA methylation in mammals","volume":"6","author":"Li","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.02.012_bib0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","article-title":"Targeted mutation of the DNA methyltransferase gene results in embryonic lethality","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.02.012_bib0046","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nature10443","article-title":"The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes","volume":"477","author":"Gu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0047","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41588-018-0232-7","article-title":"Insights into imprinting from parent-of-origin phased methylomes and transcriptomes","volume":"50","author":"Zink","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0048","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","article-title":"Central precocious puberty caused by mutations in the imprinted gene MKRN3","volume":"368","author":"Abreu","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201600264","article-title":"C\/D-box snoRNAs form methylating and non-methylating ribonucleoprotein complexes: Old dogs show new tricks","volume":"39","author":"Falaleeva","year":"2017","journal-title":"Bioessays"},{"key":"10.1016\/j.trsl.2019.02.012_bib0050","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddp585","article-title":"The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing","volume":"19","author":"Kishore","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0051","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1118265","article-title":"The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C","volume":"311","author":"Kishore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.02.012_bib0052","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molcel.2016.10.007","article-title":"Unusual processing generates SPA LncRNAs that sequester multiple RNA binding proteins","volume":"64","author":"Wu","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2019.02.012_bib0053","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/hmg\/10.23.2687","article-title":"The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A","volume":"10","author":"Runte","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0054","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/srep06445","article-title":"Differential regulation of non-protein coding RNAs from Prader-Willi Syndrome locus","volume":"4","author":"Galiveti","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2019.02.012_bib0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ng.158","article-title":"Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C\/D box small nucleolar RNA cluster","volume":"40","author":"Sahoo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0056","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ejhg.2014.103","article-title":"Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi syndrome","volume":"23","author":"Bieth","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0057","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ejhg.2010.102","article-title":"Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C\/D box snoRNA cluster in Prader-Willi syndrome","volume":"18","author":"Duker","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0058","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddp263","article-title":"A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism","volume":"18","author":"de Smith","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0059","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ng.2968","article-title":"The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome","volume":"46","author":"Stelzer","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/ng.2776","article-title":"Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism","volume":"45","author":"Schaaf","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diseases4010002","article-title":"Prader-Willi syndrome and Schaaf-Yang syndrome: neurodevelopmental diseases intersecting at the MAGEL2 gene","volume":"4","author":"Fountain","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.trsl.2019.02.012_bib0062","first-page":"45","article-title":"The phenotypic spectrum of Schaaf-Yang syndrome: 18 new affected individuals from 14 families","author":"Fountain","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0063","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jmedgenet-2017-105222","article-title":"Chitayat-Hall and Schaaf-Yang syndromes: a common aetiology: expanding the phenotype of MAGEL2-related disorders","volume":"55","author":"Jobling","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0064","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ajhg.2015.08.010","article-title":"Truncating mutations of MAGEL2, a gene within the Prader-Willi locus, are responsible for severe arthrogryposis","volume":"97","author":"Mejlachowicz","year":"2015","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.trsl.2019.02.012_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V","article-title":"Prader-Willi and Angelman syndromes: sister imprinted disorders","volume":"97","author":"Cassidy","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0066","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1210\/jc.2003-030205","article-title":"Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome","volume":"88","author":"Haqq","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0067","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader Willi syndrome","volume":"8","author":"Cummings","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0068","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.a.36810","article-title":"Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia","volume":"167A","author":"Kweh","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0069","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2007-2138","article-title":"Hyperghrelinemia precedes obesity in Prader-Willi syndrome","volume":"93","author":"Feigerlova","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI88648","article-title":"Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome","volume":"127","author":"Burnett","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.012_bib0071","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI91307","article-title":"Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?","volume":"127","author":"Polex-Wolf","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.012_bib0072","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/ajmg.a.40491","article-title":"Dietary intake in youth with Prader-Willi syndrome","volume":"176","author":"Mackenzie","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0073","first-page":"138","article-title":"Sequelae of GH treatment in children with PWS","volume":"14","author":"Tauber","year":"2016","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.trsl.2019.02.012_bib0074","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0075","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2016-2962","article-title":"Growth hormone treatment in children with Prader-Willi syndrome: three years of longitudinal data in prepubertal children and adult height data from the KIGS database","volume":"102","author":"Bakker","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0076","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jcpp.12601","article-title":"Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome","volume":"58","author":"Dykens","year":"2017","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.trsl.2019.02.012_bib0077","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2018-00687","article-title":"Improved mental and motor development during 3 years of GH treatment in very young children with Prader-Willi syndrome","volume":"103","author":"Donze","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2019.02.012_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.98333","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","volume":"3","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2019.02.012_bib0079","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/7854_2017_28","article-title":"Oxytocin and Prader-Willi syndrome","volume":"35","author":"Kabasakalian","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.trsl.2019.02.012_bib0080","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2019.02.012_bib0081","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCO.0000000000000391","article-title":"A review of clinical trials of oxytocin in Prader-Willi syndrome","volume":"31","author":"Rice","year":"2018","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.trsl.2019.02.012_bib0082","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00335-013-9454-2","article-title":"Recommendations for the investigation of animal models of Prader-Willi syndrome","volume":"24","author":"Resnick","year":"2013","journal-title":"Mamm Genome"},{"key":"10.1016\/j.trsl.2019.02.012_bib0083","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1073\/pnas.96.16.9258","article-title":"A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes","volume":"96","author":"Gabriel","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.012_bib0084","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/8.8.1357","article-title":"Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome","volume":"8","author":"Tsai","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0085","doi-asserted-by":"crossref","first-page":"e1709","DOI":"10.1371\/journal.pone.0001709","article-title":"SnoRNA Snord116 (Pwcr1\/MBII-85) deletion causes growth deficiency and hyperphagia in mice","volume":"3","author":"Ding","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.012_bib0086","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1371\/journal.pgen.0030235","article-title":"Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation","volume":"3","author":"Skryabin","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0087","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/13828","article-title":"Disruption of the mouse necdin gene results in early post-natal lethality","volume":"23","author":"Gerard","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0088","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/8722","article-title":"Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome","volume":"22","author":"Tsai","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0089","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/hmg\/ddm225","article-title":"Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome","volume":"16","author":"Bischof","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0090","doi-asserted-by":"crossref","first-page":"e4291","DOI":"10.1371\/journal.pone.0004291","article-title":"Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice","volume":"4","author":"Mercer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.012_bib0091","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/90067","article-title":"The SNRPN promoter is not required for genomic imprinting of the Prader-Willi\/Angelman domain in mice","volume":"28","author":"Bressler","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0092","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0598-25","article-title":"A mouse model for Prader-Willi syndrome imprinting-centre mutations","volume":"19","author":"Yang","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0093","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/ddr262","article-title":"A new deletion refines the boundaries of the murine Prader-Willi syndrome imprinting center","volume":"20","author":"Dubose","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0094","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijpo.12177","article-title":"Mechanisms of obesity in Prader-Willi syndrome","volume":"13","author":"Khan","year":"2018","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.trsl.2019.02.012_bib0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0096","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0097","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrd.2016.256","article-title":"Marked for death: targeting epigenetic changes in cancer","volume":"16","author":"Pfister","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.trsl.2019.02.012_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197372","article-title":"Small molecule inhibitors and CRISPR\/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation","volume":"13","author":"Thomenius","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.012_bib0099","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetics in cancer: fundamentals and Beyond","volume":"173","author":"Biswas","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2019.02.012_bib0100","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.chembiol.2017.08.020","article-title":"Drug discovery and chemical biology of cancer epigenetics","volume":"24","author":"Ribich","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic therapeutics: a new weapon in the war against cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.10-3-176","article-title":"FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension","volume":"10","author":"Kaminskas","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.trsl.2019.02.012_bib0103","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/138920106778521523","article-title":"DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML","volume":"7","author":"Muller","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.trsl.2019.02.012_bib0104","article-title":"Recent progress in histone deacetylase inhibitors as anticancer agents","author":"Cappellacci","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.trsl.2019.02.012_bib0105","article-title":"A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma","author":"Teknos","year":"2018","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.trsl.2019.02.012_bib0106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0108","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrd4580","article-title":"Prospects for the development of epigenetic drugs for CNS conditions","volume":"14","author":"Szyf","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.trsl.2019.02.012_bib0109","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/hmg\/10.6.645","article-title":"Association of acetylated histones with paternally expressed genes in the Prader-Willi deletion region","volume":"10","author":"Fulmer-Smentek","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.012_bib0111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/hmg\/ddm288","article-title":"The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology","volume":"17","author":"Dindot","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.3-1-11","article-title":"The Role of topotecan in the treatment of small cell lung cancer","volume":"3","author":"Brahmer","year":"1998","journal-title":"Oncologist"},{"key":"10.1016\/j.trsl.2019.02.012_bib0113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13229-018-0228-2","article-title":"Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome","volume":"9","author":"Lee","year":"2018","journal-title":"Mol Autism"},{"key":"10.1016\/j.trsl.2019.02.012_bib0114","article-title":"Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.02.012_bib0115","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1073\/pnas.250426397","article-title":"Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization","volume":"97","author":"Cavaille","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.012_bib0116","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1101\/gad.1452206","article-title":"Deficiency of Rbbp1\/Arid4a and Rbbp1l1\/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS\/AS domain","volume":"20","author":"Wu","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.trsl.2019.02.012_bib0117","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/hmg\/8.13.2497","article-title":"The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region","volume":"8","author":"Boccaccio","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0118","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/geno.2001.6543","article-title":"The Prader-Willi syndrome imprinting center activates the paternally expressed murine Ube3a antisense transcript but represses paternal Ube3a","volume":"73","author":"Chamberlain","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.trsl.2019.02.012_bib0119","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/dds130","article-title":"Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a","volume":"21","author":"Meng","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.297","article-title":"Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells","volume":"41","author":"Wen","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0121","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/hmg\/ddu187","article-title":"Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs","volume":"23","author":"Cruvinel","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0122","doi-asserted-by":"crossref","first-page":"e15082","DOI":"10.1371\/journal.pone.0015082","article-title":"ZNF274 recruits the histone methyltransferase SETDB1 to the 3\u2032 ends of ZNF genes","volume":"5","author":"Frietze","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.012_bib0123","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/hmg\/ddx420","article-title":"Zinc finger protein 274 regulates imprinted expression of transcripts in Prader-Willi syndrome neurons","volume":"27","author":"Langouet","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0124","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.trsl.2019.02.012_bib0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.187","article-title":"Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57","volume":"40","author":"Mackay","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.02.012_bib0126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/jmedgenet-2013-102149","article-title":"A familial disorder of altered DNA-methylation","volume":"51","author":"Caliebe","year":"2014","journal-title":"J Med Genet"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419300489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419300489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:12:44Z","timestamp":1778832764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524419300489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":126,"alternative-id":["S1931524419300489"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.02.012","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic therapy of Prader\u2013Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}